COVID-19 news: India gets third vaccine as Russia's Sputnik V gets nod for emergency use

Credit: DNA- Published on April 12, 2021
This is the third COVID-19 vaccine approved by the Subject Expert Committee (SEC) after Covishield and Covaxin.

Video credit: KMTV Action 3 News
Published on April 12, 2021 -  03:08
Vaccinations for 12 to 15-year-olds could be available in weeks
Local medical experts believe now that Pfizer has applied for Emergency Use Authorization for their COVID vaccine for those 12-15, that age group could be eligible for a vaccine by the end of the month. Approval will take a few weeks. This, as Douglas County cases soar in those 19 and younger.

You are here


💡 newsR Knowledge: Other News Mentions


Sputnik V COVID-19 vaccine

Vaccine against COVID-19
RDIF, which is the Russian sovereign wealth fund that has funded the vaccine, has signed pacts with 5 Indian companies to produce 850 million doses.
Credit: DNA - Published 11 hours ago

India has given approval to Sputnik V and the first consignment arrived in the country on May 1.
Credit: DNA - Published 3 days ago




Related videos from verified sources

Vaccine in numbers: a third of adults in England have now had both doses of the Covid-19 vaccine 00:39
Credit: PA - Press Association STUDIO - Published 4 hours ago 


India has 37,36,648 active COVID-19 cases till date 01:59
Credit: ANI - Published 14 hours ago 


Covid update: Decongesting jails; DRDO's new oral drug; task force for oxygen 03:24
Credit: HT Digital Content - Published 1 day ago 


Related news from verified sources

This is the third COVID-19 vaccine approved by the Subject Expert Committee (SEC) after Covishield and Covaxin.
on April 12, 2021 • DNA

Amid concerns about the need to step up Covid-19 vaccination, India is soon expected to get its third shot against the infection with the drug regulator’s...
on April 12, 2021 • IndiaTimes

You might like